Literature DB >> 2002375

Gangliosides: the relevance of current research to neurosurgery.

F A Rodden1, H Wiegandt, B L Bauer.   

Abstract

Gangliosides are complex glycolipids found on the outer surface of most cell membranes: they are particularly concentrated in tissues of the nervous system. Gangliosides form part of the immunological identity of mammalian cells and are involved in a variety of cell-surface phenomena such as cell-substrate binding and receptor functions. In tumorous tissue, the ganglioside composition is altered, sometimes in direct proportion to the degree of malignancy. The literature on the glycosphingolipid composition and immunology of intracranial tumors is reviewed. Some gangliosides induce neuritogenesis and exhibit a trophic effect on nerve cells grown in vitro. In vivo, a particular ganglioside, GM1, reduces cerebral edema and accelerates recovery from injury (traumatic and ischemic) to the peripheral and central nervous systems of laboratory animals. Preliminary clinical studies have shown that treatment with gangliosides may have corresponding effects on lesions of the human peripheral nervous system. Gangliosides have not been tested in human subjects with brain injury.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2002375     DOI: 10.3171/jns.1991.74.4.0606

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  8 in total

1.  Ganglioside GT1b suppresses immunoglobulin production by human peripheral blood mononuclear cells.

Authors:  N Kanda; K Tamaki
Journal:  Immunology       Date:  1999-04       Impact factor: 7.397

2.  Gangliosides and neutral glycolipids in ependymal, neuronal and primitive neuroectodermal tumors.

Authors:  A J Yates; T K Franklin; P McKinney; R Collins; T Comas; C P Boesel; D K Pearl
Journal:  J Mol Neurosci       Date:  1999-04       Impact factor: 3.444

3.  The Therapeutic Role of Gangliosides in Neurological Disorders.

Authors:  J S Schneider
Journal:  CNS Drugs       Date:  1994-03       Impact factor: 5.749

4.  Quantitative studies of monoclonal antibody targeting to disialoganglioside GD2 in human brain tumors.

Authors:  E Arbit; N K Cheung; S D Yeh; F Daghighian; J J Zhang; C Cordon-Cardo; K Pentlow; A Canete; R Finn; S M Larson
Journal:  Eur J Nucl Med       Date:  1995-05

5.  Binding and transport of gangliosides by prosaposin.

Authors:  M Hiraiwa; S Soeda; Y Kishimoto; J S O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

6.  Gangliosides induce autophagic cell death in astrocytes.

Authors:  Jaegyu Hwang; Shinrye Lee; Jung Tae Lee; Taeg Kyu Kwon; Deok Ryong Kim; Ho Kim; Hae-Chul Park; Kyoungho Suk
Journal:  Br J Pharmacol       Date:  2010-01-08       Impact factor: 8.739

7.  Gangliosides in meningiomas: correlation of Glac2 to intermediary filament.

Authors:  G Pausch; R Jennemann; H D Mennel; B L Bauer; A F Rodden; H Wiegandt
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

Review 8.  Cholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by type I and type II heat-labile enterotoxins.

Authors:  Terry D Connell
Journal:  Expert Rev Vaccines       Date:  2007-10       Impact factor: 5.217

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.